A Leading Global
End-To-End CDMO

About Porton

Founded in 2005, Porton Pharma Solutions Ltd.is an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for small molecule, Large molecule and Gene and Cell Therapies from pre-clinical to commercialization. With more than 5000 skilled employees working across more than 20 sites around the globe, Porton is committed to becoming the most open, innovative and reliable pharmaceutical service platform in the world and enabling the public’s early access to good medicines.Porton is publicly listed on the Shenzhen Stock Exchange (Ticker: 300363).


Trusted Partner

Our facilities operate under full compliance to first-class international standards

  • 80%

    Top 20 Big pharma

  • 800+

    Accumulated clients

  • 200+

    Active customers

  • 200+


Business Consulting

Please select what you want to consult

  • Requirement
  • Virtual Tour
  • On-Site Visit

Your information has been submitted successfully